Skip to content
Glaucoma treatments continue to advance beyond traditional eye drops.
In this video Dr. Kurt Schwiesow, MD, a fellowship-trained glaucoma specialist at Tower Clock Eye Center, explains why he uses iDoseTR rather than Durysta for glaucoma management. Durysta is a temporary medication implant that generally lowers eye pressure for only a few months and is not repeatable. iDoseTR is designed for sustained pressure reduction and offers a repeatable treatment option for long-term glaucoma care.
If you’ve been recommended Durysta, it may be worthwhile to seek a second opinion from a fellowship-trained glaucoma specialist to better understand all available treatment options.
Learn how iDoseTR may help reduce dependence on daily drops while providing ongoing glaucoma management for appropriate patients.
